All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Grade Code | NCIT_C93573 | [A coded value specifying the position on a scale of intensity or amount or quality.] |
| Highlighted Indicator | NCIT_C93575 | [Specifies whether an event or entity is pointed out or emphasized.] |
| Hospitalization Required Indicator | NCIT_C93576 | [Specifies whether the subject requires hospitalization or prolongation of existing hospitalization.] |
| Guaifenesin-DM | NCIT_C29083 | [A combination preparation containing guaifenesin and the opioid agonist dextrometorphan with expectorant and antitussive activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Dextrometorphan, a synthetic, methylated dextrorotary analogue of levorphanol, exhibits antitussive activity by activating opioid receptors in the cough center in the central nervous system, thereby raising the threshold for coughing.] |
| Malignant Neuroectodermal Cell with Hyperchromatic Nucleus and Scanty Cytoplasm | NCIT_C54040 | |
| Malignant Neuroectodermal Cell | NCIT_C53987 | |
| Guaifenesin/Pseudoephedrine | NCIT_C29084 | [A combination preparation containing guaifenesin and the indirect-acting sympathicomimetic agent pseudoephedrine with expectorant and decongestant activities, respectively. Guaifenesin works by drawing water into respiratory tracts, by which reducing adhesiveness and surface tension of mucus as well as increasing hydration of mucus, thereby reducing the viscosity of mucus and making cough more productive. Pseudoephedrine displaces norepinephrine from storage vesicles in presynaptic neurons, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors in the nasal mucosa, thereby producing vasoconstriction, reduces swelling of nasal mucous membranes and decreasing nasal and sinus congestion.] |
| SPINT1 Gene | NCIT_C107610 | [This gene plays a role in the regulation of hepatocyte growth factor maturation.] |
| Nodular, Reticulin-Free Zones Present | NCIT_C54041 | |
| HIV Peptide Vaccine | NCIT_C29085 | [A vaccine containing one or more peptides derived from the human immunodeficiency virus (HIV). As a vaccine antigen, an HIV peptide may stimulate the host immune response against HIV, thereby preventing or treating HIV infection. (NCI04)] |
| SPINT1 wt Allele | NCIT_C107611 | [Human SPINT1 wild-type allele is located in the vicinity of 15q15.1 and is approximately 14 kb in length. This allele, which encodes Kunitz-type protease inhibitor 1 protein, is involved in both the inhibition of proteolysis and the modulation of growth factor signaling.] |
| Malignant Neuroectodermal Round Cell | NCIT_C54042 | |
| HIVgP160 Vaccine | NCIT_C29086 | [A synthetic HIV vaccine based on a recombinant canary pox virus vector expressing the human immunodeficiency virus (HIV) glycoprotein gp160. HIVgP160 vaccine has been used to generate in vivo primary T lymphocyte response against HIV antigens. (NCI04)] |
| Kunitz-Type Protease Inhibitor 1 | NCIT_C107612 | [Kunitz-type protease inhibitor 1 (529 aa, ~58 kDa) is encoded by the human SPINT1 gene. This protein plays a role in both growth factor signaling and the regulation of protease activity.] |
| Malignant Neuroectodermal Large Cell | NCIT_C54043 | |
| ADRA2C Gene | NCIT_C107613 | [This gene is involved in the regulation of neurotransmitter release.] |
| Malignant Neuroectodermal Small Cell | NCIT_C54044 | |
| Neoplastic Small Neuroepithelial Cell | NCIT_C41835 | |
| HPV 16 L1-VLP | NCIT_C29088 | [A vaccine consisting of human papillomavirus-derived noninfectious virus-like particles (VLPs), containing the L1 major capsid protein. Vaccination with HPV 16 L1-VLP results in increases in T cell-proliferative response to HPV 16 L1-VLP, as well as significant increases in cytokine (interferon-gamma, interleukin-5 and -10) responses to L1 VLP. This agent may reduce the incidence of persistent HPV-16 infection, which may be responsible for half of all cases of cervical cancer including high-grade cervical intraepithelial neoplasia. (NCI04)] |
| ADRA2C wt Allele | NCIT_C107614 | [Human ADRA2C wild-type allele is located in the vicinity of 4p16 and is approximately 2 kb in length. This allele, which encodes alpha-2C adrenergic receptor protein, plays a role in the inhibition of G protein-coupled receptor-mediated adenylate cyclase activity.] |